Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:57:46.336Z.
Calculation as of: 2026-10-06T17:57:46.336Z.
Quote observation: 2026-10-06T17:55:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2a0cb01cc31f7f7a1ab27ea5f4e27b2bab80fdffd2dde3b1d08905865647984d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Paranovus Entertainment Technology Ltd.
Market Cap
$3.25M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| Paranovus Entertainment Technology Ltd. (PAVS) | $3.25M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.16M | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | N/A |
| Revelation Biosciences, Inc. (REVB)vs › | $3.05M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.01M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
